How has Rapid Micro Biosystems's accrued liabilities, current changed year-over-year?

Rapid Micro Biosystems's accrued liabilities, current increased by 29.0% year-over-year, from $5.03M to $6.5M.

What is the long-term trend for Rapid Micro Biosystems's accrued liabilities, current?

Over 5 years (2020 to 2025), Rapid Micro Biosystems's accrued liabilities, current has grown at a 4.6% compound annual growth rate (CAGR), from $6.65M to $8.32M.

Rapid Micro Biosystems RPID Accrued Liabilities, Current

Accrued Liabilities, Current at other companies

Charles River LaboratoriesCRL

——

Pacific Biosciences of CaliforniaPACB

——

West Pharmaceutical ServicesWST

——

Lifecore Biomedical, Inc.LFCR

——

Fulgent Genetics, Inc.FLGT

——

Biodesix, Inc.BDSX

——

Other financials

Income statement

See full

Revenue$8.0M+11.1%

Gross profit$371.0K-8.2%

Operating income-$13.9M-18.8%

Net income-$14.3M-26.7%

EPS (diluted)-$0.31-19.2%

Balance sheet

See full

Cash & equivalents$14.1M-26.8%

Total debt$23.8M+301%

Total equity$20.4M-68.9%

Total assets$62.4M-27.0%

Cash flow

See full

Operating cash flow-$15.1M-66.1%

CapEx$394.0K+23.5%

Free cash flow-$15.5M-64.7%

Valuation

See full

Market cap$86.19M-43.8%

Enterprise value$95.86M-31.7%

P/S2.5×-2.6×

Profitability

See full

Operating margin-144.2%-12.7pp

Net margin-145.8%-5.0pp

FCF margin-110.5%-14.9pp

Returns & leverage

See full

Return on equity-116.7%-620pp

Debt / equity1.2×+1.1×

Current ratio2.6×-2.0×

Where this comes from

Reported directly by Rapid Micro Biosystems in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: Rapid Micro Biosystems’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rapid Micro Biosystems's accrued liabilities, current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rapid Micro Biosystems's accrued liabilities, current?: Rapid Micro Biosystems (RPID) reported accrued liabilities, current of $6.5M in Q1 2026.
How has Rapid Micro Biosystems's accrued liabilities, current changed year-over-year?: Rapid Micro Biosystems's accrued liabilities, current increased by 29.0% year-over-year, from $5.03M to $6.5M.
What is the long-term trend for Rapid Micro Biosystems's accrued liabilities, current?: Over 5 years (2020 to 2025), Rapid Micro Biosystems's accrued liabilities, current has grown at a 4.6% compound annual growth rate (CAGR), from $6.65M to $8.32M.